Literature DB >> 15472896

Genomic instability in multiple myeloma: evidence for jumping segmental duplications of chromosome arm 1q.

Jeffrey R Sawyer1, Guido Tricot, Janet L Lukacs, Regina Lichti Binz, Erming Tian, Bart Barlogie, John Shaughnessy.   

Abstract

Multiple myeloma (MM) is a malignant plasma cell disorder characterized by complex karyotypes and chromosome 1 instability at the cytogenetic level. Chromosome 1 instability generally involves partial duplications, whole-arm translocations, or jumping translocations of 1q, identified by G-banding. To characterize this instability further, we performed spectral karyotyping and fluorescence in situ hybridization with probes for satII/III (1q12), BCL9 (1q21), and IL6R (1q21) on the karyotypes of 44 patients with known 1q aberrations. In eight patients, segmental duplication of 1q12-21 and adjacent bands occurred on nonhomologous chromosomes. In five cases, the 1q first jumped to a nonhomologous chromosome, after which the 1q12-21 segment again duplicated itself 1-3 times. In three other cases, segmental duplications occurred after the 1q first jumped to a nonhomologous chromosome, where the proximal adjacent nonhomologous chromosome segment was duplicated prior to the 1q jumping or inserting itself into a new location. These cases demonstrate that satII/III DNA sequences are not only associated not only with the duplication of adjacent distal chromosome segments after translocation, but are also associated with the duplication and jumping/insertion of proximal nonhomologous chromosome segments. We have designated this type of instability as a jumping segmental duplication.

Entities:  

Mesh:

Year:  2005        PMID: 15472896     DOI: 10.1002/gcc.20109

Source DB:  PubMed          Journal:  Genes Chromosomes Cancer        ISSN: 1045-2257            Impact factor:   5.006


  24 in total

1.  The molecular classification of multiple myeloma.

Authors:  Fenghuang Zhan; Yongsheng Huang; Simona Colla; James P Stewart; Ichiro Hanamura; Sushil Gupta; Joshua Epstein; Shmuel Yaccoby; Jeffrey Sawyer; Bart Burington; Elias Anaissie; Klaus Hollmig; Mauricio Pineda-Roman; Guido Tricot; Frits van Rhee; Ronald Walker; Maurizio Zangari; John Crowley; Bart Barlogie; John D Shaughnessy
Journal:  Blood       Date:  2006-05-25       Impact factor: 22.113

2.  Genome-wide copy number analysis in pediatric glioblastoma multiforme.

Authors:  Laura Giunti; Marilena Pantaleo; Iacopo Sardi; Aldesia Provenzano; Alberto Magi; Stefania Cardellicchio; Francesca Castiglione; Lorenzo Tattini; Francesca Novara; Anna Maria Buccoliero; Maurizio de Martino; Lorenzo Genitori; Orsetta Zuffardi; Sabrina Giglio
Journal:  Am J Cancer Res       Date:  2014-05-26       Impact factor: 6.166

3.  Amplification and overexpression of E2 ubiquitin conjugase UBE2T promotes homologous recombination in multiple myeloma.

Authors:  David A Alagpulinsa; Subodh Kumar; Srikanth Talluri; Purushothama Nanjappa; Leutz Buon; Chandraditya Chakraborty; Mehmet K Samur; Raphael Szalat; Masood A Shammas; Nikhil C Munshi
Journal:  Blood Adv       Date:  2019-12-10

4.  Evidence of an epigenetic origin for high-risk 1q21 copy number aberrations in multiple myeloma.

Authors:  Jeffrey R Sawyer; Erming Tian; Christoph J Heuck; Donald J Johann; Joshua Epstein; Charles M Swanson; Janet L Lukacs; Regina Lichti Binz; Marian Johnson; Gael Sammartino; Maurizio Zangari; Faith E Davies; Frits van Rhee; Gareth J Morgan; Bart Barlogie
Journal:  Blood       Date:  2015-05-05       Impact factor: 22.113

Review 5.  Evolutionary biology of high-risk multiple myeloma.

Authors:  Charlotte Pawlyn; Gareth J Morgan
Journal:  Nat Rev Cancer       Date:  2017-08-24       Impact factor: 60.716

6.  CKS1B nuclear expression is inversely correlated with p27Kip1 expression and is predictive of an adverse survival in patients with multiple myeloma.

Authors:  Hong Chang; Nan Jiang; Hua Jiang; Manujendra N Saha; Connie Qi; Wei Xu; Donna Reece
Journal:  Haematologica       Date:  2010-04-26       Impact factor: 9.941

7.  CKS1B, overexpressed in aggressive disease, regulates multiple myeloma growth and survival through SKP2- and p27Kip1-dependent and -independent mechanisms.

Authors:  Fenghuang Zhan; Simona Colla; Xiaosong Wu; Bangzheng Chen; James P Stewart; W Michael Kuehl; Bart Barlogie; John D Shaughnessy
Journal:  Blood       Date:  2007-02-15       Impact factor: 22.113

8.  Definitive molecular cytogenetic characterization of 15 colorectal cancer cell lines.

Authors:  Turid Knutsen; Hesed M Padilla-Nash; Danny Wangsa; Linda Barenboim-Stapleton; Jordi Camps; Nicole McNeil; Michael J Difilippantonio; Thomas Ried
Journal:  Genes Chromosomes Cancer       Date:  2010-03       Impact factor: 5.006

9.  BCL9 promotes tumor progression by conferring enhanced proliferative, metastatic, and angiogenic properties to cancer cells.

Authors:  Mala Mani; Daniel E Carrasco; Yunyu Zhang; Kohichi Takada; Moshe E Gatt; Jui Dutta-Simmons; Hiroshi Ikeda; Felipe Diaz-Griffero; Victor Pena-Cruz; Monica Bertagnolli; Lois L Myeroff; Sanford D Markowitz; Kenneth C Anderson; Daniel R Carrasco
Journal:  Cancer Res       Date:  2009-09-08       Impact factor: 12.701

10.  Jumping translocations of 1q12 in multiple myeloma: a novel mechanism for deletion of 17p in cytogenetically defined high-risk disease.

Authors:  Jeffrey R Sawyer; Erming Tian; Christoph J Heuck; Joshua Epstein; Donald J Johann; Charles M Swanson; Janet L Lukacs; Marian Johnson; Regina Binz; Angela Boast; Gael Sammartino; Saad Usmani; Maurizio Zangari; Sarah Waheed; Frits van Rhee; Bart Barlogie
Journal:  Blood       Date:  2014-02-04       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.